Treatment and diagnostics astrocytoma in Tokyo, Japan

Treatment of astrocytoma in Tokyo is a scheme of measures aimed at destroying the tumor, identifying and inactivating its disseminated lesions, and preventing future relapses. Therapy is carried out by the best oncologists, radiologists, neurosurgeons, and chemotherapy specialists with a global reputation. They regularly develop innovative approaches to minimize common risks and achieve a stronger therapeutic effect.

Astrocytoma is a malignant brain tumor. It responds to treatment better than glioblastoma, but it is still dangerous and insidious. Diagnosis of astrocytoma in Tokyo is carried out by physical, instrumental, and laboratory methods.

These include:

• blood tests, including tumor markers and gene mutation tests,
• MRI of the brain and MR angiography of cerebral arteries,
• X-ray of the skull,
• CT and MSCT of the head with contrast,
• rheoencephalography,
• electroencephalography,
• echoencephalography,
• stereotactic biopsy under MRI guidance.

The following procedures are used for treatment:

• polychemotherapy and monochemotherapy,
• high-dose liposomal chemotherapy,
• brachytherapy,
• traditional radiotherapy,
• ultrasound therapy for pilocytic forms,
• molecular targeted therapy,
• treatment with monoclonal antibodies,
• stereotactic radiosurgery (focused irradiation with gamma knife, nano knife, or cyber knife).

In addition to targeted measures, patients are prescribed restorative therapy that improves immunity, tones the body, and helps relieve symptoms. Thanks to the effort and dedication of local doctors, most people treated in local clinics return home healthy.